Upcoming Events

INDUSTRY CONFERENCEs

 
HTAi2019_MainTheme_SociaMedia_300px.png

HTAi 2019 Annual Meeting

15 - 19 June 2019
Cologne, German

The Context Matters team will be presenting new insights and leading an expert panel discussion on the globalization of HTAs at this year’s HTAi Annual Meeting.

Vignette Presentations

VP34: The Impact of Adverse Events on Reimbursement Recommendations
Monday, 17 June 4:25 PM – 4:55 PM

VS79: Reimbursement of NSCLC and MS Drugs with High ICER Values: Key Drivers
Wednesday, 19 June 8:00 AM – 8:30 AM

Panel Discussion

Unified vs. Localized HTA Systems: What are the Considerations?

Our panel of experts will present differing perspectives on how the trends towards more globalized health technology assessments has impacted market access.

  • What are the advantages and disadvantages of globalized vs. localized HTAs?
  • What are more globalized approaches being implemented, what are their limits?
  • How do different approaches impact pricing decisions? To what extent can pricing be globalized?

Panel

Zoe Garrett   Senior Technical Adviser at EUnetHTA National Institute for Health and Care Excellence, United Kingdom

Zoe Garrett
Senior Technical Adviser at EUnetHTA National Institute for Health and Care Excellence, United Kingdom

Anita D. Burrell  SVP, Global Market Access Insights, Health Strategies Insights, an EVERSANA company

Anita D. Burrell
SVP, Global Market Access Insights, Health Strategies Insights, an EVERSANA company

Indranil Bagchi  Senior Vice President and Head of Global Value and Access, Novartis Oncology

Indranil Bagchi
Senior Vice President and Head of Global Value and Access, Novartis Oncology

Rachel Jao (Moderator)  VP, Accounts & Analytical Services, Context Matters, A Decision Resources Group company

Rachel Jao (Moderator)
VP, Accounts & Analytical Services, Context Matters, A Decision Resources Group company

Cameron Lockwood   Consulting Associate Director,  IHS Markit

Cameron Lockwood
Consulting Associate Director,
IHS Markit